Tetravalent neutralizing antibody response against four dengue serotypes by a single chimeric dengue envelope antigen
- 1 January 2006
- Vol. 24 (3) , 335-344
- https://doi.org/10.1016/j.vaccine.2005.07.100
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriersHepatology, 2004
- DNA vaccines—back in the saddle again?Nature Biotechnology, 2004
- Dengue 2 PDK-53 Virus as a Chimeric Carrier for Tetravalent Dengue Vaccine DevelopmentJournal of Virology, 2003
- Chimeric Co-stimulatory Molecules That Selectively Act through CD28 or CTLA-4 on Human T CellsPublished by Elsevier ,2002
- Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero CellsJournal of Virology, 2001
- Construction, Safety, and Immunogenicity in Nonhuman Primates of a Chimeric Yellow Fever-Dengue Virus Tetravalent VaccineJournal of Virology, 2001
- Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteersVaccine, 2001
- A DNA vaccine expressing dengue type 2 virus premembrane and envelope genes induces neutralizing antibody and memory B cells in miceVaccine, 2000
- Analysis of C-terminally truncated dengue 2 and dengue 3 virus envelope glycoproteins: processing in insect cells and immunogenic properties in miceJournal of General Virology, 1994
- Pathogenesis of Dengue: Challenges to Molecular BiologyScience, 1988